<DOC>
<DOCNO>
EP-0007591
</DOCNO>
<TEXT>
<DATE>
19800206
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/63 A61K-31/635 A61K-47/00 A61K-9/08 <main>A61K-31/635</main> A61K-47/22 
</IPC-CLASSIFICATIONS>
<TITLE>
stable medicinal solution on the basis of 2,6-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine(trimethoprim) and a sulphonamide, process for preparing and using it.
</TITLE>
<APPLICANT>
ciba geigy agch<sep>ciba-geigy ag<sep>ciba-geigy agklybeckstrasse 1414002 baselch<sep>ciba-geigy ag  <sep>
</APPLICANT>
<INVENTOR>
atasoy kaya dr<sep>lukas gerhard dr<sep>atasoy, kaya, dr.<sep>lukas, gerhard, dr.<sep>atasoy, kaya, dr.loogstrasse 32ch-4142 münchensteinch<sep>lukas, gerhard, dr.in den wegscheiden 16ch-4132 muttenzch<sep>atasoy, kaya, dr.<sep>lukas, gerhard, dr.<sep>atasoy, kaya, dr.loogstrasse 32ch-4142 münchensteinch<sep>lukas, gerhard, dr.in den wegscheiden 16ch-4132 muttenzch<sep>
</INVENTOR>
<ABSTRACT>
Stable water-containing liquid formulation containing an active ingredient combination of 2,6-diamino-5- (3 ', 4', 5'-trimethoxybenzyl) - pyrimidine (trimethoprime) and a sulfo namid of the formula in which R 6-chloro-2-pyrazinyl or6-chloro-3-pyridazinyl means, or a salt thereof for controlling bacterial and protozoary diseases in animals using drinking water application.Except for the mentioned rods, the formulation further contains N-methyl pyrrolidone as solvent.A solubilizer, a surfactant and water.
</ABSTRACT>
</TEXT>
</DOC>
